The malignant psoas syndrome revisited: case report, mechanisms, and current therapeutic options.
The malignant psoas syndrome (MPS) is a rare and challenging cancer pain state that is often refractory to rational polymodal analgesic therapy. We describe the first case of cervix cancer-related MPS due to extrinsic psoas muscle infiltration and review the therapeutic trajectory and outcome. The anatomic determinants, pain mechanisms, and current and proposed novel treatment strategies for MPS are discussed.
Stevens
Mark John
MJ
Department of Palliative Medicine, Hope Health Care, Sydney, New South Wales, Australia. mjstevens@ausdoctors.net
Atkinson
Charlotte
C
Broadbent
Andrew M
AM
D000777:Anesthetics; D004358:Drug Therapy; D005260:Female; D006801:Humans; D008160:Lumbosacral Plexus / Q000473:pathology; D008875:Middle Aged; D010148:Intractable Pain / Q000188:drug therapy; D010166:Palliative Care / Q000379:methods*; D016658:Psoas Muscles / Q000473:pathology*; D013035:Spasm / Q000188:drug therapy*; D013577:Syndrome; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy
D000777:Anesthetics